Direct Head-to-Head Evaluation of Recombinant Adeno-associated Viral Vectors Manufactured in Human versus Insect Cells-Reference-Cited by-同舟云学术

Direct Head-to-Head Evaluation of Recombinant Adeno-associated Viral Vectors Manufactured in Human versus Insect Cells

Published:2017-12 Issue:12 Volume:25 Page:2661-2675
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Kondratov Oleksandr,Marsic Damien,Crosson Sean M.,Mendez-Gomez Hector R.,Moskalenko Oleksandr,Mietzsch Mario,Heilbronn Regine,Allison Jonathan R.,Green Kari B.,Agbandje-McKenna Mavis,Zolotukhin Sergei

Funder

NIH/NHLBI

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference48 articles.

1. The VP1 capsid protein of adeno-associated virus type 2 is carrying a phospholipase A2 domain required for virus infectivity;Girod;J. Gen. Virol.,2002

2. Structural proteins of adenovirus-associated viruses;Rose;J. Virol.,1971

3. Structural proteins of adenovirus-associated virus type 3;Johnson;J. Virol.,1971

4. Characterization of adenovirus-associated virus-induced polypeptides in KB cells;Buller;J. Virol.,1978

5. Defining the stoichiometry and cargo load of viral and bacterial nanoparticles by Orbitrap mass spectrometry;Snijder;J. Am. Chem. Soc.,2014

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The longitudinal kinetics of AAV5 vector integration profiles and evaluation of clonal expansion in mice;Molecular Therapy - Methods & Clinical Development;2024-09

2. Production of recombinant adeno-associated virus 5 using a novel self-attenuating adenovirus production platform;Molecular Therapy - Methods & Clinical Development;2024-09

3. Therapeutic Application and Structural Features of Adeno-Associated Virus Vector;Current Issues in Molecular Biology;2024-08-02

4. A robust and flexible baculovirus-insect cell system for AAV vector production with improved yield, capsid ratios and potency;Molecular Therapy - Methods & Clinical Development;2024-06

5. Characterizing the Biopotency of Truncated Transgene Variants in rAAV8 viral vectors: Essential Considerations for Gene Therapy Applications;2024-04-04